What We're Reading: Pharmacists Can Prescribe Birth Control in Oregon, California
What we're reading, November 23, 2015: Oregon and California both pass laws that authorize pharmacists to prescribe birth control; the US and Europe are approving more drugs; and Turing discounts Daraprim just 50% and only for hospitals.
What We're Reading: CMS Wants to Penalize Doctors for Prostate Tests
What we're reading, November 20, 2015: CMS wants to penalize doctors for ordering routine prostate-cancer screening tests; lawmakers, patients, and advocates call for head of Drug Enforcement Agency to be fired; and specialty drug costs exceed household incomes.
What We're Reading: AMA Wants to Ban TV Ads for Drugs
What we're reading, November 19, 2015: the American Medical Association is calling for a ban on direct-to-consumer television advertisement of prescription drugs and popular silver plans on HealthCare.gov have largest premium increases.
What We're Reading: Global Drug Spending Will Hit $1.3 Trillion in 2020
What we're reading, November 18, 2015: global drug spending is expected to grow 30% in 5 years; Robert M. Califf, MD, sits through mostly friendly senate confirmation hearing for FDA nomination; and moderate coffee consumption could reduce some risks of death.
What We're Reading: Antibiotic Misuse Fuels Rise of Drug-Resistant Superbugs
What we're reading, November 17, 2015: misunderstanding of antibiotics has fueled the rise of drug-resistant superbugs; healthcare leaders overwhelmingly support government intervention to curb rising cost of drugs; and the FDA wants more regulation on laboratory-developed tests.
What We're Reading: Consumers Shocked by High Deductibles on ACA Plans
What we're reading, November 16, 2015: consumers face sticker shock on Affordable Care Act plans when they get sick and face high deductibles; Medicare spending on hepatitis C drugs nearly doubled in 2015; and US maternal mortality has worsened since 1990.
What We're Reading: Public Housing Smoking Ban
What we're reading, November 12, 2015: nationwide ban on smoking in public houses could have a huge economic impact; CMS barrier to sharing patient records on drug and alcohol abuse; an urgent care—ED hybrid model could save unnecessary costs.
What We're Reading: Annual Flu Shots Can Reduce Effectiveness of Vaccine
What we're reading, November 11, 2015: annual flu shots may reduce the effectiveness of the vaccine; Democrats call for changes to the so-called Cadillac tax; and Millennium Health files for chapter 11 bankruptcy.
What We're Reading: Medi-Cal May Be Expanded to Illegal Immigrants
What we're reading, November 10, 2015: half of California's illegal immigrants would be eligible for Medi-Cal if it was expanded; women are less likely to receive optimal care after a heart attack, which accounts for survival gap; and Hawaii's residents face long wait times to sign up for health coverage on HealthCare.gov.
What We're Reading: Americans Skeptical About Patient-Centered Care Benefits
What we're reading, November 9, 2015: Americans worry patient-centered care is a gimmick; insurers raise new concerns over the increasing prices for generic drugs; and President Obama challenges 20 cities to sign up the most uninsured on the exchanges.
What We're Reading: Americans Want Healthcare Costs Kept in Check
What we're reading, November 6, 2015: Americans want more aggressive measures to keep healthcare costs in check; the uninsured rate fell to 9% in the first half of 2015; and the federal government warns against restricting access to pricey hepatitis C drugs.
What We're Reading: Drug Deaths a Presidential Election Issue
What we're reading, November 4, 2015: drug deaths become the next big 2016 presidential campaign issue; and Blue Shield of California and Anthem Blue Cross receive large fines for misleading information about Affordable Care Act Plans.
What We're Reading: Off-Label Drug Use and Adverse Drug Events
What we're reading, November 3, 2015: off-label drug use is associated with a higher risk of adverse drug events; CMS finalizes its rule for advanced care planning for end-of-life care; and Californians send measure to cut drug prices to the vote.
Novartis COPD Dual Combination Bronchodilator Approved
Novartis' dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. It is not indicated to treat asthma or sudden symptoms of COPD.
What We're Reading: Fewer Plans Expected on HealthCare.gov
What we're reading, October 29, 2015: Fewer health plans will be available on HealthCare.gov in 2016; PBMs cut ties with pharmacy connected to Valeant; and emergency departments are dissatisfied with electronic health record interoperability.
What We're Reading: Ben Carson's Plan to Overhaul Healthcare
What we're reading, October 28, 2015: Ben Carson plans to replace the Affordable Care Act, Medicaid, and Medicare; a homeless shelter utilizes telemedicine to alleviate emergency department visits; and researchers uncover gender gap in post-heart attack treatment.
What We're Reading: New HealthCare.gov Site More User Friendly
What we're reading, October 27, 2015: a much-improved Healthcare.gov website, report says drug prices rose at a much slower rate in 2015, and USPSTF recommends glucose testing in asymptomatic adults who are overweight or obese.
Ensuring the Use of Required Test for COPD
Despite the fact that post-bronchodilator spirometry is required for the diagnosis of chronic obstructive pulmonary disease, an analysis of primary care clinics found only 19% of patients diagnosed with the disease had undergone spirometry testing.